Oxbow Advisors’s PacWest Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of % Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A PACWP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-60,649
Closed -$1.52M 249
2022
Q3
$1.52M Buy
+60,649
New +$1.56M 0.24% 72

Other funds holding PACWP

Oxbow Advisors's PACWP Position: Q4 2022 in Review

Oxbow Advisors sold out of PacWest Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of % Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A (PACWP) in Q4 2022, closing a stake of 60,649 shares — an estimated $1.52M sold.

Oxbow Advisors first reported a position in PACWP in Q3 2022 and held it in 1 quarter. The position peaked at $1.52M in Q3 2022. 3 funds tracked by Wall St. Rank hold PACWP as of Q4 2022.

  • Oxbow Advisors reported no remaining PacWest Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of % Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A position as of Q4 2022 after selling out during the quarter.
  • Oxbow Advisors sold 60,649 PacWest Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of % Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A shares in Q4 2022, an estimated $1.52M.
  • Oxbow Advisors first reported a position in PacWest Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of % Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A in Q3 2022 and held it in 1 quarter.
  • Oxbow Advisors's PacWest Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of % Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A position peaked at $1.52M in Q3 2022.
  • 3 funds tracked by Wall St. Rank held PacWest Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of % Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A as of Q4 2022.

Based on Oxbow Advisors's 13F filing for Q4 2022, filed 1 Feb 2023.